These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 34676158)
21. Systematic analysis of survival-associated alternative splicing signatures uncovers prognostic predictors for head and neck cancer. Liang Y; Song J; He D; Xia Y; Wu Y; Yin X; Liu J J Cell Physiol; 2019 Sep; 234(9):15836-15846. PubMed ID: 30740675 [TBL] [Abstract][Full Text] [Related]
22. Prognostic value and potential function of splicing events in prostate adenocarcinoma. Huang ZG; He RQ; Mo ZN Int J Oncol; 2018 Dec; 53(6):2473-2487. PubMed ID: 30221674 [TBL] [Abstract][Full Text] [Related]
23. Identification of prognostic alternative splicing signature in gastric cancer. Wang Z; Wu Q; Liu Y; Li Q; Li J Arch Public Health; 2022 May; 80(1):145. PubMed ID: 35614517 [TBL] [Abstract][Full Text] [Related]
24. Identification of a prognostic alternative splicing signature in oral squamous cell carcinoma. Zhang S; Wu X; Diao P; Wang C; Wang D; Li S; Wang Y; Cheng J J Cell Physiol; 2020 May; 235(5):4804-4813. PubMed ID: 31637730 [TBL] [Abstract][Full Text] [Related]
25. Systematic Identification of Survival-Associated Alternative Splicing Events in Kidney Renal Clear Cell Carcinoma. Wei Y; Zhang Z; Peng R; Sun Y; Zhang L; Liu H Comput Math Methods Med; 2021; 2021():5576933. PubMed ID: 33959190 [TBL] [Abstract][Full Text] [Related]
26. Alternative Splicing Events and Splicing Factors Are Prognostic in Adrenocortical Carcinoma. Lv J; He Y; Li L; Wang Z Front Genet; 2020; 11():918. PubMed ID: 33101358 [TBL] [Abstract][Full Text] [Related]
27. Genome-wide profiling of prognosis-related alternative splicing signatures in sarcoma. Hong W; Zhang W; Guan R; Liang Y; Hu S; Ji Y; Liu M; Lu H; Yu M; Ma L Ann Transl Med; 2019 Oct; 7(20):557. PubMed ID: 31807538 [TBL] [Abstract][Full Text] [Related]
28. Survival-associated alternative splicing signatures in esophageal carcinoma. Mao S; Li Y; Lu Z; Che Y; Sun S; Huang J; Lei Y; Wang X; Liu C; Zheng S; Zang R; Li N; Li J; Sun N; He J Carcinogenesis; 2019 Mar; 40(1):121-130. PubMed ID: 30304323 [TBL] [Abstract][Full Text] [Related]
29. Identification of Prognostic Alternative Splicing Signature in Breast Carcinoma. Zhang D; Duan Y; Cun J; Yang Q Front Genet; 2019; 10():278. PubMed ID: 30984247 [TBL] [Abstract][Full Text] [Related]
30. Exploration of predictive and prognostic alternative splicing signatures in lung adenocarcinoma using machine learning methods. Cai Q; He B; Zhang P; Zhao Z; Peng X; Zhang Y; Xie H; Wang X J Transl Med; 2020 Dec; 18(1):463. PubMed ID: 33287830 [TBL] [Abstract][Full Text] [Related]
31. Alternative splicing events implicated in carcinogenesis and prognosis of thyroid gland cancer. Wu ZH; Tang Y; Zhou Y Sci Rep; 2021 Mar; 11(1):4841. PubMed ID: 33649373 [TBL] [Abstract][Full Text] [Related]
32. Germ Cell-Specific Gene 1-Like Protein Regulated by Splicing Factor CUGBP Elav-Like Family Member 5 and Primary Bile Acid Biosynthesis are Prognostic in Glioblastoma Multiforme. Huang R; Li Z; Li C; Wang G; Yan P; Peng L; Wang J; Zhu X; Hu P; Zhang J; Chang Z; Huang Z; Cheng L; Zhang J Front Genet; 2019; 10():1380. PubMed ID: 32117422 [TBL] [Abstract][Full Text] [Related]
33. Identification of prognostic alternative splicing signatures in uveal melanoma. Xie X; Zheng X; Xie T; Cai J; Yao Y Int Ophthalmol; 2021 Apr; 41(4):1347-1362. PubMed ID: 33479809 [TBL] [Abstract][Full Text] [Related]
34. Systematic Analyses of the Differentially Expressed Alternative Splicing Events in Gastric Cancer and Its Clinical Significance. Lin C; Yu B; Zhang M; Chen Y; Li L; Zhao D Front Genet; 2020; 11():522831. PubMed ID: 33281863 [TBL] [Abstract][Full Text] [Related]
35. Identification of survival-related alternative splicing signatures in acute myeloid leukemia. Zhang B; Yang L; Wang X; Fu D Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34212178 [TBL] [Abstract][Full Text] [Related]
36. Survival-Associated Alternative Messenger RNA Splicing Signatures in Pancreatic Ductal Adenocarcinoma: A Study Based on RNA-Sequencing Data. Zhou YJ; Zhu GQ; Zhang QW; Zheng KI; Chen JN; Zhang XT; Wang QW; Li XB DNA Cell Biol; 2019 Nov; 38(11):1207-1222. PubMed ID: 31483163 [TBL] [Abstract][Full Text] [Related]
37. Survival-Associated Alternative Splicing Events and Prognostic Signatures in Pancreatic Cancer. Xu L; Pan J; Ding Y; Pan H Front Genet; 2020; 11():522383. PubMed ID: 33193606 [TBL] [Abstract][Full Text] [Related]
38. Comprehensive Analysis of Alternative Splicing Signature in Gastric Cancer Prognosis Based on The Cancer Genome Atlas (TCGA) and SpliceSeq Databases. Cheng X; Li X; Gu Y; Zhou L; Tang J; Dai X; Jiang H; Huang Y; Zhang Y; Xu T; Liu Z; Zhao Q Med Sci Monit; 2020 Nov; 26():e925772. PubMed ID: 33219199 [TBL] [Abstract][Full Text] [Related]
39. Identification of Prognostic alternative splicing signatures and their clinical significance in uveal melanoma. Zhou W; Fei P; Li J Exp Eye Res; 2021 Aug; 209():108666. PubMed ID: 34129849 [TBL] [Abstract][Full Text] [Related]
40. Comprehensive Analysis of Prognostic Alternative Splicing Signatures in Endometrial Cancer. Chen P; He J; Ye H; Jiang S; Li Y; Li X; Wan J Front Genet; 2020; 11():456. PubMed ID: 32547595 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]